Doctor HAN has been engaged in clinical research on the diagnosis and treatment of lung diseases and tumors for more than 40 years. He is one of the earliest experts in China to initiate research on targeted therapy for lung cancer, molecular epidemiology of lung cancer, and combined immunotherapy.

Specializing in lung cancer diagnosis and multidisciplinary treatment, with a particular emphasis on the management of early-stage complex pulmonary nodules and the integration of radiotherapy with targeted immunotherapy in advanced-stage lung cancer. In addition, he is also committed to new drug research, leading his team to conduct and complete more than 100 clinical studies on new drugs for lung cancer